The mission of the foundtion is to ccelerte the trnsltion of lbortory bsed reserch into clinicl trils for tretments nd cures of retinl degenertive diseses. The gol of the foundtion is to develop bridge between scientific, clinicl, governmentl, phrmceuticl nd finncil communities to dvnce clinicl trils of cndidte phrmceuticl nd genetic therpies nd delivery systems for orphn retinl degenertive diseses (RDD’s). In this regrd, the foundtion wishes to educte the scientific nd clinicl communities of opportunities nd processes of drug discovery. s medicl reserch institute, the foundtion will serch for cndidte therpies nd explore new pthogenetic pthwys of retinl diseses to further the drug discovery process. The foundtion will rise funds to support Phse I nd Phse II clinicl trils in order to expedite the commerciliztion of cndidte therpies for RDD ptients. The foundtion will lso provide ssistnce to the mngement of clinicl trils nd subsequent commerciliztion.
